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Abstract
Recent genetic-based studies have implicated a number of immune-related genes in the pathogenesis of inflammatory
bowel disease (IBD). Our recent genetic studies showed that RAC2 is associated with human IBD; however, its role in disease
pathogenesis is unclear. Given Rac2’s importance in various fundamental immune cell processes, we investigated whether
a defect in Rac2 may impair host immune responses in the intestine and promote disease in the context of an infection-
based (Citrobacter rodentium) model of colitis. In response to infection, Rac22/2mice showed i) worsened clinical symptoms
(days 13–18), ii) increased crypt hyperplasia at days 11 and 22 (a time when crypt hyperplasia was largely resolved in wild-
type mice; WT), and iii) marked mononuclear cell infiltration characterized by higher numbers of T (CD3+) cells (day 22),
compared to WT-infected mice. Moreover, splenocytes harvested from infected Rac22/2mice and stimulated in vitro with C.
rodentium lysate produced considerably higher levels of interferon-c and interleukin-17A. The augmented responses
observed in Rac22/2 mice did not appear to stem from Rac2’s role in NADPH oxidase-driven reactive oxygen species
production as no differences in crypt hyperplasia, nor inflammation, were observed in infected NOX22/2 mice compared to
WT. Collectively, our findings demonstrate that Rac22/2 mice develop more severe disease when subjected to a C.
rodentium-induced model of infectious colitis, and suggest that impaired Rac2 function may promote the development of
IBD in humans.
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Introduction
Inflammatory bowel disease (IBD) is a family of chronic,
relapsing and remitting, inflammatory disorders of the gastroin-
testinal tract [1,2]. The available evidence suggests that IBD
develops as a result of an exaggerated immune response directed
against the host microbiota. Despite considerable research the
precise etiology of these diseases remains largely uncertain [3]. As
there is no cure, and treatments are geared primarily at alleviating
intestinal inflammation and symptoms, there is an urgent need to
identify the determinants that predispose the development of IBD.
Improved understanding of the causes of IBD will undoubtedly aid
in the development of more effective treatment strategies.
In addition to various environmental factors it is clear that
genetic factors also influence susceptibility to IBD. Recent genetic
based studies have identified greater than 100 genetic loci as being
associated with the development of IBD [2,4,5]. Of the numerous
genes implicated by these studies, many are known to be integrally
involved in various aspects of the immune response including,
pathogen recognition, cytokine/growth factor signalling, intestinal
epithelial barrier function and defense, and lymphocyte activation,
among others.
We have recently identified several single nucleotide poly-
morphisms (SNPs) in the gene encoding RAC2, a small guanosine
triphosphatase (GTPase) that is almost exclusively expressed in
leukocytes [6]. RAC2 is one of four regulatory cytosolic subunits
(the other three being p40phox, p47phox, p67phox) that together with
two transmembrane components gp91phox (Nox2) and p22phox
constitute the predominant nicotinamide adenine dinucleotide
phosphate (NADPH) oxidase (Nox) complex in leukocytes [7,8].
The functional requirement for RAC2 in various immune cell-
related processes has been explored in several in vitro-based studies
using, primarily, macrophages and neutrophils; two cell types of
the innate immune response that are critically required for
protection against microbes. Collectively, previous findings dem-
onstrate that in the absence of Rac2, macrophages and/or
neutrophils display suppressed reactive oxygen species (ROS)
production, defective chemotaxis, impaired phagocytosis, and
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Figure 1. Rac22/2 mice infected with Citrobacter rodentium display worsened signs of disease. Separate groups of wild-type (WT; white
bars/symbols) and Rac22/2 (black bars/symbols) mice were infected with C. rodentium or given vehicle control (sham) by orogastric gavage. (A)
Percent weight change (relative to day 0) and (B) clinical symptoms score in WT and Rac22/2 uninfected (circles) and infected (squares) mice. (C)
Scoring of goblet cell loss at day 22 of infection. n = 4–11/group. Data are expressed as mean 6 SEM and are from one of three independent
experiments. Statistical analysis was performed using two-way ANOVA with Tukey’s post hoc test.
doi:10.1371/journal.pone.0061629.g001
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decreased microbial killing [9,10,11,12,13,14,15,16,17,18]. Im-
portantly, the involvement of Rac2 in immunity is not limited to
cells of the innate arm. Indeed, Rac2-deficiency has also been
shown to impact B- and T-cell migration, activation, development
(to a lesser extent in T-cells) [19,20,21,22,23], and, in some
reports, T-cell differentiation into T-helper type 1 (Th1) cells
[21,24]. The contribution of Rac2 to host defense responses in vivo
has been less well studied. Rac22/2 mice infected intradermally
with Leishmania major displayed little to no impaired ability to clear
infection [21]. However, in a separate report Rac22/2 mice
challenged intravenously with the opportunistic pathogen Aspergil-
lus fumigatus, showed marked increases in mortality, decreased
survival time to death, and increased pathogen loads, compared to
infected wild-type (WT) mice [13]. Interestingly, a dominant-
negative mutation in RAC2 (D57N) has been described in two
case reports of infants less than eight-weeks of age [25,26,27,28].
Both patients suffered from repeated life-threatening bacterial
infections necessitating stem cell transplantation. Together, the
evidence from these in vivo reports further support the notion that
impairments in RAC2 may compromise host defenses against, at
least some, pathogens.
Whether defects in RAC2 impact the intestinal immune
response, in vivo, and influence the development of IBD is
unknown. Given the putative importance of RAC2 to immunity
and the strong connection between altered immune functioning
and IBD pathogenesis, we investigated the impact of defective
Rac2 function on the intestinal immune response and the
development of disease using a model of Citrobacter rodentium-
induced colitis. Our findings show that Rac22/2 mice infected
with C. rodentium develop worsened symptoms, augmented and
protracted colonic epithelial hyperplasia, and marked colitis
associated with heightened T-cell responsiveness.
Materials and Methods
Ethics Statement
Experiments described in this study were carried out in
accordance with the Guide for the Humane Use and Care of
Laboratory Animals and were approved by the University of
Toronto (Toronto, ON, Canada; #9558) and The Hospital for
Sick Children’s Animal Care Committees (Toronto, ON, Canada;
# 13639).
Animals
Previously generated and characterized Rac22/2 and wild-type
(WT) mice (on a Balb/c.129Sv background) were bred as
previously described at the University of Toronto Animal Care
Facility [14], and maintained as separate lines. The genotypes of
WT and Rac22/2 mice were confirmed by PCR analysis on tail
DNA as previously described [13]. C57BL/6 and gp91phox2/2
(Cybb/tm1d; Stock#2365) mice were purchased from The
Jackson Laboratory (Bar Harbor, ME). All experiments were
performed with 7–9 week old male mice that were maintained on
a 12-hour light-dark cycle, with food and water available ad libitum.
Infection
C. rodentium, strain DBS100 (ATCC #51459), was kindly
provided by Dr. Philip Sherman (The Hospital for Sick Children
in Toronto; originally from David Schauer, Massachusetts In-
Figure 2. Kinetic analysis of Citrobacter rodentium-induced
colonic hyperplasia in Rac22/2 and WT mice. Separate groups of
wild-type (WT; white bars) and Rac22/2 (black bars) mice were infected
with C. rodentium or given vehicle control (sham) by orogastric gavage.
(A-B) Pictures show representative light photomicrographs of hema-
toxylin and eosin stained paraffin-embedded cross-sections of colon
tissue obtained at the indicated time points of infection. Scale bar
100 mm. (C) Morphometric analysis of colonic hyperplasia; data
represent average crypt length. All pictures were taken at 106original
magnification. n = 4–10/group. Data are expressed as mean 6 SEM and
are from one of three (in A) or two (in B) independent experiments.
Statistical analysis was performed using two-way ANOVA with Tukey’s
post hoc test.
doi:10.1371/journal.pone.0061629.g002
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Figure 3. Prolonged colonic hyperplasia in Rac22/2 mice develops due to continued epithelial cell proliferation. Separate groups of
wild-type (WT; white bars) and Rac22/2 (black bars) mice were infected with Citrobacter rodentium or given vehicle control (sham) by orogastric
gavage. (A) Immunofluorescence for Ki-67. Pictures show representative images of Ki-67 stained paraffin-embedded cross-sections of colon tissue
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stitute of Technology). Bacteria were grown on Luria broth (LB)
plates overnight at 37uC, followed by overnight culture in LB
broth at 37uC without shaking. C. rodentium (36108 cfu) was
administered to mice by orogastric gavage in 200 ml of LB broth.
Vehicle control mice were given an equal volume of sterile LB
broth.
Collection and Measurement of Specimens
Mice were monitored every other day for weight change, stool
consistency, rectal bleeding, and general appearance. At the
indicated time points, colon (terminal 3 cm starting from ,0.5 cm
away from the anus) and spleen were collected. Following
dissection, the lumen of the colon was washed, gently, with sterile
PBS using a feeding needle. The terminal 0.75 cm of the colon
was cut and fixed in 10% formalin for 24 hours for histochemical
and morphometric analysis. Where applicable, the remaining
,2.25 cm were collected in PBS for leukocyte isolation and flow
cytometric analysis. Harvested spleens were placed in sterile tubes
containing sterile Hank’s Balanced Salt Solution (HBSS) for
splenocyte culture.
Histological and Clinical Symptoms Scoring
Inflammatory infiltrate and goblet cell loss were scored by
a pathologist blinded to the experimental conditions based on the
scoring system used in [29] and shown in Table S1. The clinical
symptoms score was adapted from [29] and calculated as shown in
Table S2.
Histology and Immunohistochemistry
After formalin fixation, the colon was cut cross-sectionally in
half, yielding two pieces of tissue. Tissues were embedded in
paraffin, and two separate 3-mm-thick cross-sections (.100 mm
apart) were cut and stained with hematoxylin and eosin (H&E).
Immunohistochemistry for Ki-67, C. rodentium, and CD3 were
performed using the protocol previously described in detail [30],
with the following changes: tissues were not incubated in
permeabilization buffer, heat-induced epitope retrieval was
performed using a vegetable steamer and slides were boiled (95–
100uC) in sodium citrate buffer for 25–30 minutes, and tissues
were incubated in block solution for 45–60 minutes. The following
antibodies were used: rat anti-mouse Ki-67 (TEC-3; Dako; 1:250),
rabbit anti-C. rodentium (generated by the Sherman Lab, The
Hospital for Sick Children, 1:250), rabbit anti-CD3 (polyclonal,
Sigma, 1:2000), goat anti-rabbit AlexaFluor 488 and 568
(Molecular Probes, 1:200) and donkey anti-rat Cy3 (Jackson
ImmunoResearch Laboratories Inc, 1:200).
Morphometric Analysis
H&E stained sections were visualized using a Leica DMI 6000B
microscope, Leica DFC420 camera and Leica Application Suite
Advanced Fluorescence software (Leica, Toronto, ON). Crypt
length was assessed by microscopy on coded sections by a single
blinded observer. A minimum of 15, non-adjacent and well-
orientated, crypts were measured per sample and used to
determine the average crypt length/mouse. Images and morpho-
metric analysis of Ki-67, C. rodentium, and CD3 were captured and
analyzed using Volocity (v6.0; Perkin Elmer, Billerica, Massachu-
setts) via a Hamamatsu Orca R2 camera and Nikon Ti-E
microscope. Multiple images were taken of the colon cross-section
of each individual mouse (,5–10 at 206magnification, encom-
passing 95% of each section). For quantification of Ki-67+ cells in
the crypts, the number of Ki-67+ cells/crypt was counted manually
by a blinded observer; a minimum of 15 crypts were counted per
sample. For quantification of colonic epithelial-associated C.
rodentium, a ‘region of interest’ was drawn to encompass all of the
colon tissue observable in a given image, being careful to exclude
luminal contents. Within this ‘region of interest’, a colour intensity
was selected that best captured the stain of interest and minimized
or eliminated background staining. The total areas of both the
‘region of interest’ and the stained area were quantified and
weighted averages were calculated for each individual mouse. The
data shown represent the average percentage of the area of interest
that is stained with C. rodentium. Similarly for CD3, a ‘region of
interest’ was identified, the total area quantified, and Volocity used
to determine the number of cells stained positive for CD3 (on the
basis on signal intensity) within this region. The data shown
represent the average number of CD3+ cells per unit of area.
Colonic Cell Isolation and Flow Cytometric Analysis
Leukocytes of the lamina propria were isolated from the colon
by mechanical digestion, using a method similar to that described
in [31] with modification. Colon pieces (,2.25 cm) were, first, cut
longitudinally, and then cross-sectionally in pieces of ,0.5 cm in
length. Tissues were then incubated in 5 ml Ca2+/Mg2+ free
HBSS supplemented with 10 mM Hepes, 5 mM ethylenediamine
tetra-acetic acid, and 1 mM dithiothreitol, pH 7.4 for 20 minutes
at 37uC in a shaker. Tissues were then vortexed vigorously for
,5 s and dissociated cells in the supernatant (predominantly
epithelial) were separated by pouring the mixture through
a 100 mm cell strainer (BD PharMingen, Mississauga, ON). Tissue
pieces were returned to a fresh 5 ml aliquot of HBSS solution and
the process was repeated for a total of four times. Tissues were
then washed with FACS buffer (0.5% bovine serum albumin in
PBS) to remove traces of EDTA, chopped into 1–2 mm pieces and
incubated in RPMI supplemented with 25 mM Hepes and 0.125
Wunsch units/ml Liberase-TM (Roche, Laval, Quebec) for
approximately 50–60 minutes at 37uC with shaking. The resulting
tissue fragments and supernatant were poured through a 40 mm
cell strainer, crushed with the plunger of a 3 ml syringe and rinsed
with FACS Buffer. Cells were subsequently pelleted (1400 rpm for
10 minutes at 4uC), washed once with FACS buffer, and
resuspended in a final volume of 0.5–1 ml. Total cell counts were
then performed by trypan blue counting. Each sample was filtered
again through a 40 mm cell strainer prior to surface marker
staining. For staining, cells were first incubated with FcBlock (anti-
CD16/CD32; BD PharMingen, Mississauga, ON, Canada) in
FACS buffer for 15 minutes at 4uC (to minimize nonspecific
binding). Antibodies were titrated to determine optimal concen-
tration. For each antibody combination, 26106 cells were
incubated with mAbs on ice for 30 minutes. Cells were then
washed twice with FACS buffer, fixed in 2.5% paraformaldehyde
for 20 minutes on ice, and washed once more. Data were collected
using a LSRIITM (BD) flow cytometer and analyzed using
FlowJoTM software (Tree Star Inc., Ashland, OR, USA). The
following antibodies were used: anti-CD4 (fluoresceine-isothiocya-
nate-conjugated RM4-5 clone), anti-CD45 (Alexa-Fluor 700-
conjugated 30-F11 clone), purchased from BD PharMingen;
obtained at the indicated time points of infection. Scale bar 100 mm. (B) Morphometric analysis of Ki-67 staining; data represent the average number
of Ki-67+ cells/crypt. All pictures were taken at 206original magnification. n = 5–7/group. Data are expressed as mean6 SEM and are from one of two
independent experiments. Statistical analysis was performed using two-way ANOVA with Tukey’s post hoc test.
doi:10.1371/journal.pone.0061629.g003
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anti-CD3 (eFluor450-conjugated 500A2 clone), purchased from
ebioscience (San Diego, CA, USA). The following gating strategy
was used: whole leukocytes were first selected on the basis of CD45
expression, then ‘singlets’ were identified using FSC-W vs. FSC-A.
CD4+ and CD8+ T cells were then identified by gating on the
lymphocyte area on a graph of SSC vs FSC-A, and subsequently
gating on CD4+ or CD8+ cells within the CD3+ population of the
lymphocyte region. The ‘absolute cell numbers’ were calculated by
multiplying the appropriate population percentages by the total
cell count for each sample.
Splenocyte Culture
Splenocytes were isolated by triturating whole spleens through
a 40 mm cell strainer (BD), using the plunger from a 3 ml syringe,
into HBSS. Cells were then centrifuged at 1200 rpm for 10
minutes at 4uC and red blood cells were lysed using ACK lysis
buffer. HBSS was used to stop lysis after 1 minute (1:10 volume
ratio). Splenocytes were then washed in complete RPMI (RPMI
supplemented with 10% FBS – Sigma Aldrich; 1% L-glutamine;
1% penicillin/streptomycin – Invitrogen, Grand Island, NY, USA;
and 0.1% b-mercaptoethanol – Invitrogen). Splenocytes were then
resuspended in complete RPMI at a concentration of 66106 cells/
ml and cultured in medium alone, or with medium supplemented
with a C. rodentium lysate (7.5 mg/ml; prepared by repeated rounds
of freeze-thaw and sonication of live C. rodentium) in a round-
bottom, 96-well plate (BD), in triplicate; 100 ml of medium 6
lysate +100 ml of cell suspension per well. After 3 days of culture,
supernatants were harvested and triplicates were pooled and
stored at 220uC for cytokine measurements.
Cytokine Measurements by ELISA
Levels of mouse interleukin (IL)-4, -17A and interferon (IFN)-c
were measured by ELISA using DuoSet kits purchased from R&D
Systems (Minneapolis, MN, USA) and performed according to the
manufacturer’s instructions. Each of these assays has a threshold of
detection between 2–10 pg/ml.
Data Analysis
Data were analyzed using SigmaStat v3.0 (SPSS Inc., Chicago,
IL). Data are expressed as mean 6 SEM. Results were analyzed
using two-way analysis of variance (ANOVA) with Tukey’s post
hoc test. Differences were considered statistically significant at
P,0.05.
Results
C. rodentium Infection Induces Increased and Prolonged
Colonic Hyperplasia in Rac22/2 Mice
To investigate the impact of a Rac2-deficiency on intestinal
immune responses and the development of colitis, we subjected
WT and Rac22/2 mice to a model of C. rodentium induced colitis.
Separate groups of mice were infected (day1) with C. rodentium by
oral gavage and sacrificed on days 11 and 22 of infection, time
points that represent peak and resolution stages of infection,
respectively. In response to infection, Rac22/2 mice displayed
weight loss, a worsened clinical symptoms score (days 12–18), and
considerable goblet cell loss (day 22; Figure 1) compared to
infected WT mice. As expected, we observed that colonic
Figure 4. Epithelial-associated Citrobacter rodentium is cleared
by WT and Rac22/2mice at day 22 of infection. Separate groups
of wild-type (WT; white bars) and Rac22/2 (black bars) mice were
infected with C. rodentium or given vehicle control (sham) by orogastric
gavage. (A-B) Immunofluorescence for epithelial cell-associated C.
rodentium. Pictures show representative stitched images of DAPI and
C. rodentium co-stained paraffin-embedded cross-sections of colon
tissue obtained at days 11 (A) and 22 (B) of infection. Scale bar 200 mm.
(C) Morphometric analysis of C. rodentium staining; data represent the
percentage of the total tissue area that is stained positive for C.
rodentium. Individual images were taken at 106 and stitched together
using image analysis software to create a composite cross-section.
n = 6–8/group. Data are expressed as mean 6 SEM and are from one of
two independent experiments. Statistical analysis was performed using
two-way ANOVA with Tukey’s post hoc test.
doi:10.1371/journal.pone.0061629.g004
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hyperplasia was significantly increased in WT infected mice
compared to uninfected (sham) controls at day 11, and that this
response had largely resolved by day 22 (Figures 2A and C).
Interestingly, Rac22/2 infected mice developed significantly
elevated hyperplasia at day 11 compared to WT mice that was
considerably increased at day 22 (Figures 2A and C). To examine
whether the colonic hyperplasia would continue to increase in
Rac22/2 mice we infected an independent cohort of mice and
measured colonic hyperplasia at day 32 of infection. Although
colonic hyperplasia remained significantly elevated over uninfect-
ed and WT infected mice at day 32, this response was decreased
relative to day 22, indicating that the hyperplasia was resolving
(Figures 2B and C).
Colonic Hyperplasia is Driven by Enhanced Epithelial Cell
Proliferation
To determine if the increase in colonic hyperplasia observed at
day 22 in Rac22/2 mice was mediated by active epithelial cell
proliferation we quantified Ki-67 staining, a marker of pro-
liferating cells, in the colon. We observed significant increases in
the number of Ki-67+ epithelial cells/crypt that were similar
between WT and Rac22/2 infected mice at day 11 of infection
Figure 5. Rac22/2 mice infected with Citrobacter rodentium develop marked mononuclear cell infiltration at day 22 of infection.
Separate groups of wild-type (WT; white bars) and Rac22/2 (black bars) mice were infected with C. rodentium or given vehicle control (sham) by
orogastric gavage. (A) Scoring of mononuclear and polymorphonuclear cell infiltration into the submucosa and/or mucosa at day 22 of infection. (B)
Average number of CD3+ cells per crypt in colon tissues obtained at day 22 of infection. (C) Flow cytometric analysis of colon digests showing the
number of total leukocytes (CD45+ cells), T-helper (CD45+ CD3+ CD4+), and cytotoxic (CD45+ CD3+ CD8+) T-cells. n = 3–8/group in (A-B) and n= 3–4/
group in (C). Data are expressed as mean6 SEM and are from one of two independent experiments. Statistical analysis was performed using two-way
ANOVA with Tukey’s post hoc test.
doi:10.1371/journal.pone.0061629.g005
Role of Rac2 in Citrobacter-Induced Colitis
PLOS ONE | www.plosone.org 7 April 2013 | Volume 8 | Issue 4 | e61629
(Figure 3). At day 22, the number of Ki-67+ cells had decreased
substantially in WT infected mice but remained elevated in
Rac22/2 infected with C. rodentium (Figure 3), demonstrating that
the increase in colonic hyperplasia in Rac22/2 mice at day 22 is,
at least in part, being driven by increased epithelial cell
proliferation.
Epithelial-associated C. rodentium is Cleared by day 22 of
Infection in WT and Rac22/2 Mice
Given the putative importance of Rac2 in various immune cell-
related functions and our observations of increased colonic
hyperplasia, we questioned whether a deficiency in Rac2
negatively impacted bacterial clearance in vivo. To this end, we
stained colon sections for the presence of C. rodentium and
quantified the amount of bacteria associated with the colonic
epithelium. Immunofluorescence analysis revealed a trend towards
increased C. rodentium presence in Rac22/2 infected mice
compared to WT controls at day 11, but this difference was not
statistically significant (Figures 4A and C). Moreover, no C.
rodentium could be detected in either strain at day 22 of infection
(Figures 4B and C). No C. rodentium was ever detected in uninfected
mice (Figure 4C). These results suggest that Rac22/2 mice are
able to control and clear the infection.
C. rodentium Infection Induces Marked Colitis in Rac22/2
Mice
Histopathological analysis revealed marked inflammation in the
colons of Rac22/2, but not WT, mice at day 22 of infection.
Scoring of the inflammatory infiltrate by a pathologist blinded to
the experimental conditions indicated that the inflammation was
mononuclear cell in nature, with few if any polymorphonuclear
cells observable at this stage of infection (Figure 5A). Immunoflu-
orescence staining for CD3 demonstrated that a large number of
these infiltrating cells were CD3+ (Figure 5B). To better quantify
the extent of T-cell infiltrate we isolated cells from the colon and
performed flow cytometric analysis to determine the number of,
Th (CD45+ CD3+ CD4+) and cytotoxic T-cells (CD45+ CD3+
CD8+). In agreement with the histopathology, we isolated
considerably higher numbers of total leukocytes (CD45+) and
detected significantly more T-cells in the colons of infected
Rac22/2 mice compared to WT-infected mice (Figure 5C). The
T-cell profile consisted predominantly of CD4+ T-cells with
a limited number of CD8+ T-cells observed (Figure 5C).
Rac22/2 Mice Infected with C. rodentium Develop
Heightened Th1 and Th17-associated Cytokine
Responses
To evaluate the impact of Rac2 deficiency on the T cell
response against C. rodentium we harvested splenocytes from
Rac22/2 and WT-infected mice and measured the production
of T cell-associated cytokines by ELISA following in vitro
stimulation with a C. rodentium lysate. Splenocytes from infected
Rac22/2 mice produced considerably more of the Th1- and
Th17-associated cytokines IFN-c and IL-17A in response to C.
rodentium than WT mice (Figure 6). No differences in IL-4
production (a Th2-associated cytokine) were observed between
WT- and Rac22/2infected mice. The proportion of Th cells in the
spleen were similar between WT and Rac22/2 mice, indicating
that the differences in IFN-c and IL-17A production observed
were not due, simply, to an aberrant, overall, increase in baseline
Th cell number resulting from genetic ablation of Rac2 (data not
shown).
Figure 6. Heightened Th1- and Th17-associated cytokine
production by splenocytes from Rac22/2 mice at day 22 of
infection. Separate groups of wild-type (WT) and Rac22/2 mice were
infected with Citrobacter rodentium or given vehicle control (sham) by
orogastric gavage. Graphs show interferon-c (IFN-c), interleukin (IL)-17A
and IL-4 production by splenocytes. Splenocytes from individual mice
were harvested at day 22 of infection and cultured in medium alone or
stimulated with C. rodentium lysate in vitro. n = 3–5/group. Statistical
analysis was performed using two-way ANOVA with Tukey’s post hoc
test. WT uninfected (white bars), WT C. rodentium-infected (light grey
bars), Rac22/2 uninfected (dark grey bars), and Rac22/2 C. rodentium-
infected (black bars).
doi:10.1371/journal.pone.0061629.g006
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Nox22/2 Mice do not Develop Exaggerated Colonic
Hyperplasia or Colitis following Infection with C.
rodentium
In light of the importance of Rac2 in NADPH oxidase-driven
ROS production in leukocytes [7,8], we questioned the extent to
which the enhanced responses observed in infected Rac22/2 mice
were related to defects in leukocyte-derived ROS production. To
address this, Nox22/2 mice were infected with C. rodentium and
colonic hyperplasia was examined at days 11 and 22 of infection.
We observed that crypt hyperplasia developed to a similar extent
in infected WT and Nox22/2 mice (Figure 7A and B). Moreover,
no significant differences were observed in the extent of C.
rodentium colonization at day 11 of infection and bacteria were
cleared from WT and Nox22/2 mice at day 22 of infection
(Figure 7C).
Discussion
Our findings demonstrate that a genetic deficiency in Rac2
leads to worsened disease in mice infected with C. rodentium as
evidenced by increased clinical symptoms score, colonic epithelial
hyperplasia and colitis. However, the infection was not severe and
all Rac22/2 mice recovered from infection. In addition, Rac22/2
mice did not appear to suffer from major innate immune defects as
might have been predicted on the basis of the findings from
previous in vitro-based studies [9,10,11,12,13,14,15,16,17,18]. We
noted that C. rodentium colonization was controlled and that all
bacteria were cleared at day 22. Moreover, there was no evidence
of systemic bacterial dissemination and no signs of colonic
hemorrhaging. A previous study examining the impact of Rac2-
deficiency on susceptibility to L. major infection reported that
intradermally-infected Rac22/2 mice displayed no differences in
disease (i.e. lesion score and pathogen burden) compared to WT-
infected mice [21]. Yet, in another report, Rac22/2 mice were
found to be more susceptible to systemic challenge with A.
fumigatus, showing increased pathogen burden and mortality [13].
These findings, in conjunction with our own, suggest that the
requirement for Rac2 in the host defense response against
pathogens may depend heavily on the pathogen itself and the
mode of infection.
How can our findings be reconciled with the findings from
human and in vitro studies that suggest that the absence of Rac2
may exert a crippling effect on several aspects of the innate
immune response, in particular, on immune phagocyte function?
With respect to the findings of the two human case reports,
interpretation of those results, as it pertains to RAC2, is somewhat
confounded by the knowledge that the mutation identified therein
is known to impart dominant-negative activity on RAC2 [26].
Thus, the observed defects in host defense responses in those
patients may have developed, in part, from consequences un-
related to impaired RAC2 function per se. For example, the
acquisition of dominant negative activity may result in the
sequestration of guanine nucleotide exchange factors (GEFs) that
activate other Rho GTPases potentially involved in distinct
immune-related signalling pathways [32]. Furthermore, it is worth
noting that in humans, RAC2 constitutes 75–95% of the total Rac
content, whereas Rac1 and Rac2 are present in roughly equal
proportions in murine neutrophils [12,33,34]. Regarding the
in vitro-based studies, we argue that the findings of these reports
may overestimate the absolute requirement for Rac2 in various
innate immune cell functions. While neutrophils and macrophages
isolated from the peripheral blood and bone marrow of Rac22/2
mice display significant defects in phagocytosis, chemotaxis and/
or ROS production, we and others propose that these cells may
not exhibit such severe deficiencies when present in the setting of
an active immune-inflammatory environment. In this regard,
neutrophils isolated from the peritoneum of Rac22/2 mice
following thioglycollate injection showed only marginal defects in
ROS production and, similarly, bone marrow-derived Rac22/2
neutrophils stimulated with tumour necrosis factor (TNF)-a showed
only a modest impairment in ROS production following
secondary stimulation [13]. Thus, in the context of activating
conditions (be they cytokine stimulation, inflammation, etc.), the
loss of Rac2 may be partially compensated for by, presumably,
other Rac isoforms. It is important to acknowledge that studies
have consistently observed marked, albeit incomplete, defects in
neutrophil chemotaxis and migration both in vitro and in vivo, in
mice and humans [11,13,14,25]. Neutrophils are known to be
a significant contributing cell type in the response mounted against
C. rodentium [35,36], although perhaps not as essential as some
other immune cells. In the studies presented here, whatever impact
the loss of Rac2 had on neutrophil migration was not sufficient
enough to impair bacterial control/clearance.
Interestingly, despite the absence of C. rodentium in Rac22/2
infected mice at day 22, we observed augmented colonic epithelial
cell hyperplasia and exaggerated inflammation in the colon. These
findings suggest that Rac2 may play a role, either directly or
indirectly, in pathways related to the regulation and/or resolution
of inflammation. That we documented dramatic increases in the
production of IFN-c and IL-17 from Rac22/2 splenocytes
recalled in vitro with C. rodentium lysate, further suggests that the
regulatory defects may lie in the processes that influence T-cell
responses.
Previous reports have demonstrated that Rac2 is involved in
various T-cell processes including migration, differentiation and
apoptosis [21,24,37,38], and defects in any of these could have
contributed to the heightened responses we observed in infected
Rac22/2 mice. The loss of Rac2 in T-cells may have affected
development of regulatory T-cells and, hence, resulted in at least
a partial loss of inflammatory regulation. The involvement of Rac2
in T-cell differentiation is not without precedent as some, although
not all, studies have shown that Rac2 plays a role in Th1 cell
differentiation [21,24]. Although our results (i.e. IFN-c production
by splenocytes) do not support the idea of impaired Th1
development in infected Rac22/2 mice, they do not rule out the
possibility that defects may exist in the differentiation pathways of
other T-cell phenotypes such as T regulatory cells. Although
somewhat unlikely, it is possible that the exaggerated immune-
responsiveness we report here is related to impaired T-cell
migration to or within the colon. Rac22/2 T-cells do exhibit
chemotactic defects in vitro and Rac22/2 mice have been reported
Figure 7. Nox22/2 mice infected with Citrobacter rodentium do not develop exaggerated colonic hyperplasia or colitis. Separate
groups of wild-type (WT; white bars) and Nox22/2 (black bars) mice were infected with C. rodentium or given vehicle control (sham) by orogastric
gavage. (A) Pictures show representative light photomicrographs of hematoxylin and eosin stained paraffin-embedded cross-sections of colon tissue
obtained at the indicated time points of infection. Scale bar 100 mm. (B) Morphometric analysis of colonic hyperplasia at the indicated time points;
data represent average crypt length. (C) Morphometric analysis of C. rodentium staining at the indicated time points of infection; data represent the
percentage of the total tissue area that is stained positive for C. rodentium. All pictures were taken at 106original magnification. n = 5–6/group. Data
are expressed as mean 6 SEM. Statistical analysis was performed using two-way ANOVA with Tukey’s post hoc test.
doi:10.1371/journal.pone.0061629.g007
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to display abnormal peripheral T-cell distribution [21]. However,
we did not observe any overt aggregations or limitations in overall
T-cell distribution (sub-mucosa vs. mucosa) in the colons of
infected Rac22/2 mice. Alternatively, Rac2-deficiency may have
impacted resolution mechanisms via some detriment to apoptosis.
Along these lines, Rac2 has been shown to be a key signalling
component of restimulation-induced cell death (RICD) [37];
a process that is thought to be an essential self-limiting negative
feedback mechanism for controlling T-cell expansion during
ongoing immune responses [39]. T-cells from Rac22/2 mice
and Rac2-siRNA treated human primary CD4+ T-cells displayed
significantly impaired TCR-induced cell death [37]. Importantly,
as RICD is thought to limit immunopathology that may arise from
excessive effector T-cell expansion [39], it is plausible that defects
in Rac2-mediated RICD may account for the exaggerated T-cell
responses and associated inflammatory and hyperplasia we report
here.
Our observations regarding C. rodentium infection in Nox22/2
mice suggest that at least some of the heightened immunorespon-
siveness we found in infected Rac22/2 mice may not be a result of
Rac2’s role in NADPH-derived ROS production. Interestingly,
previous studies that have investigated the contribution of the
Nox2 complex to host defense responses in the intestine have
reported mixed results. Mice deficient in p47phox displayed no
overt differences compared to their WT controls in response to
dextran sulphate sodium (DSS)-induced disease [40] and, in-
terestingly, gp912/2 mice were partially protected from DSS-
induced responses [41]. On the other hand, a recent study
reported that p40phox2/2 mice have increased inflammation and
more severe colonic tissue injury in both DSS and Rag12/2
mouse models of colitis [42]. The differences in these findings are
somewhat difficult to reconcile strictly in terms of the role of Nox2-
derived ROS in models of colitis, however, they may derive, in
part, from the participation of ‘Nox’ components (i.e. p40phox,
p47phox, gp91) in other, Nox2-independent, processes/signalling
pathways.
A considerable body of research supports the notion that
impairments in host immunity, be they related to inflammatory- or
regulatory-associated networks, contribute to the pathogenesis of
IBD. In the studies presented here, we sought to investigate
whether a defect in RAC2, a well-recognized mediator of various
fundamental innate and adaptive immune cell processes, may
impact host immune responses in the intestine and the de-
velopment of disease. Our findings demonstrate that Rac2-
deficient mice subjected to an infection-based model of colitis
develop worsened disease characterized by increased and
protracted colonic epithelial cell hyperplasia and exacerbated
colonic inflammation. Importantly, the findings presented here
speak to the possible contribution of variants in the RAC2 gene,
which may affect RAC2 expression and/or function, on the
development of intestinal disease in humans. The issue is of
relevance as population-based genetic studies continue to impli-
cate an increasing number of genes whose roles in the
pathogenesis of IBD are not well understood. While many of
these genes are thought to, individually, contribute only modestly
to IBD risk, their identification will, at the very least, form the basis
for more detailed analyses into the influence of gene pathways/
networks. Coupled with detailed functional studies in both
experimental models and patients, the knowledge gained is sure
to furnish a foundation that not only inspires novel development
but also guides the implementation of treatment strategies on
a patient-by-patient basis.
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